Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones And The Initiation Of A Clinical Trial Of Ecopipam In Lesch-Nyhan Disease

Links shared publicly online about this topic.

  • 1,394
    total visits

Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones And The Initiation Of A Clinical Trial Of Ecopipam In Lesch-Nyhan Disease

medicalnewstoday.com —

Psyadon Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) to study ecopipam in patients with Les

View full resource at medicalnewstoday.com

Tags: Disease and Condition, Drug, Pharma, Clinical Trial, FDA

  • Share

Most Recently Shared on February 10, 2010 at 4:06 am By:

mnt_clinical MNT Clinical Trials

Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones And The Initiation Of A Clinical Trial Of Ecopipam In Le... http://mnt.to/3xq8

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

medical_tweets medical_tweets

MNT Biology News MNT Biology News

Advertisement